Insider Trading & Ownership - Harris Erik

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Harris Erik
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-01
Sale
2024-03-05
8:08 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
4,768$53.76$256,328101,363
(Direct)
View
2023-09-05
Sale
2023-09-06
5:51 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
6,000$37.96$227,76051,281
(Direct)
View
2023-06-19
Sale
2023-06-21
6:17 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
305$48.2$14,70157,281
(Direct)
View
2023-03-01
Sale
2023-03-03
7:51 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
3,664$45.25$165,79696,744
(Direct)
View
2022-06-19
Sale
2022-06-22
7:27 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
295$54.78$16,16036,160
(Direct)
View
2022-03-01
Sale
2022-03-03
6:11 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
2,713$66.62$180,74061,217
(Direct)
View
2021-10-14
Sale
2021-10-18
6:58 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
303$81.14$24,58525,030
(Direct)
View
2021-07-06
Sale
2021-07-08
11:56 am
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
375$91.53$34,32425,333
(Direct)
View
2021-06-19
Sale
2021-06-23
5:55 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
1,009$94.82$95,67025,708
(Direct)
View
2021-05-06
Sale
2021-05-10
6:10 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
700$113.67$79,57226,717
(Direct)
View
2021-04-20
Sale
2021-04-21
8:07 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
396$104.28$41,29527,417
(Direct)
View
2021-03-01
Sale
2021-03-03
8:42 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
3,177$138.17$438,95938,813
(Direct)
View
2020-06-03
Sale
2021-02-03
8:04 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
2,516$74.69$187,92020,854
(Direct)
View
2020-10-14
Sale
2020-10-16
7:20 pm
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
220$88$19,36023,370
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-03-05
8:08 pm
N/A
2034-03-01
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
54,557$0101,363
(Direct)
View
2023-06-01
Option Award
2023-06-05
6:02 pm
N/A
2033-06-01
Denali Therapeutics Inc.DNLIHarris Erik
Director
16,865$023,734
(Direct)
View
2023-03-01
Option Award
2023-03-03
7:51 pm
N/A
2033-03-01
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
64,063$096,744
(Direct)
View
2022-03-01
Option Award
2022-03-03
6:11 pm
N/A
2032-03-01
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
38,900$061,217
(Direct)
View
2022-02-03
Option Award
2022-02-07
6:54 pm
N/A
2032-02-03
Denali Therapeutics Inc.DNLIHarris Erik
Director
27,476$027,476
(Direct)
View
2021-03-01
Option Award
2021-03-03
8:42 pm
N/A
2031-03-01
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
21,136$038,813
(Direct)
View
2020-07-06
Tax Withholding
2020-07-08
12:29 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
260$86.7523,590
(Direct)
View
2020-06-19
Tax Withholding
2020-06-22
1:47 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
303$78.2223,850
(Direct)
View
2020-05-06
Tax Withholding
2020-05-08
8:11 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
209$66.2624,153
(Direct)
View
2020-04-19
Tax Withholding
2020-04-21
3:31 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
210$58.5724,362
(Direct)
View
2020-03-01
Option Award
2020-03-03
8:02 pm
N/A
2030-03-01
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
33,087$046,572
(Direct)
View
2020-03-01
Tax Withholding
2020-03-03
8:02 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
824$56.0846,572
(Direct)
View
2019-10-14
Option Award
2019-10-16
7:32 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
1,208$014,309
(Direct)
View
2019-07-06
Tax Withholding
2019-07-09
7:40 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
260$59.5113,101
(Direct)
View
2019-06-19
Option Award
2019-06-21
8:05 pm
N/A
2029-06-19
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
15,500$025,361
(Direct)
View

Ownership
2019-06-21
8:01 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREHarris Erik
EVP & Chief Commercial Officer
0$056,761
(Direct)
View